Thrivent Financial for Lutherans Sells 2,520 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Thrivent Financial for Lutherans trimmed its position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) by 4.3% during the 3rd quarter, Holdings Channel reports. The firm owned 56,632 shares of the company’s stock after selling 2,520 shares during the period. Thrivent Financial for Lutherans’ holdings in Prestige Consumer Healthcare were worth $4,083,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of PBH. Opal Wealth Advisors LLC bought a new stake in Prestige Consumer Healthcare during the second quarter valued at about $26,000. Quest Partners LLC raised its stake in Prestige Consumer Healthcare by 2,826.7% during the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after purchasing an additional 424 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after purchasing an additional 208 shares in the last quarter. Gladius Capital Management LP bought a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after buying an additional 433 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Insider Buying and Selling at Prestige Consumer Healthcare

In other news, insider William P’pool sold 8,987 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $81.85, for a total value of $735,585.95. Following the sale, the insider now owns 20,058 shares of the company’s stock, valued at approximately $1,641,747.30. This represents a 30.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Ronald M. Lombardi sold 10,875 shares of the company’s stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total transaction of $898,275.00. Following the transaction, the chief executive officer now owns 320,952 shares in the company, valued at $26,510,635.20. The trade was a 3.28 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 38,810 shares of company stock worth $3,187,300 over the last ninety days. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on PBH shares. Jefferies Financial Group restated a “hold” rating and set a $76.00 target price (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research report on Tuesday, September 24th. DA Davidson restated a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a research report on Monday, November 11th. One research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $83.67.

Prestige Consumer Healthcare Trading Up 0.8 %

PBH stock opened at $84.85 on Monday. The firm has a market cap of $4.19 billion, a PE ratio of 20.64, a price-to-earnings-growth ratio of 2.37 and a beta of 0.47. The firm has a fifty day moving average price of $74.34 and a 200 day moving average price of $70.68. The company has a debt-to-equity ratio of 0.61, a quick ratio of 2.10 and a current ratio of 3.56. Prestige Consumer Healthcare Inc. has a fifty-two week low of $56.61 and a fifty-two week high of $85.22.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm had revenue of $283.79 million for the quarter, compared to the consensus estimate of $282.09 million. During the same period in the previous year, the firm posted $1.07 EPS. The business’s quarterly revenue was down .9% on a year-over-year basis. Sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.